Viro-immune therapy: A new strategy for treatment of pancreatic cancer
/in International Publications, Newcastle Disease Virus, Pancreatic Cancer /von 2016-01-14 / World J. Gastroenterol. 2016 Jan;22(2):748-63Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
/in Dendritic Cells, Hyperthermia, International Publications, IOZK Veröffentlichungen /von 2016-01-14 / Front Immunol 2015;6:663Long-term local control and survival after preoperative radiochemotherapy in combination with deep regional hyperthermia in locally advanced rectal cancer
/in Colorectal Cancer, Hyperthermia, International Publications /von 2016-01-11 / Int J Hyperthermia 2016;32(2):187-92Current status and perspectives of immune-based therapies for hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2016-01-07 / World J. Gastroenterol. 2016 Jan;22(1):253-61Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2016-01-06 / Viruses 2016 Jan;8(1)Artikel über IOZK in „Aktuelle Gesundheitsnachrichten“, Heft 20/2016
/in IOZK In der Presse, IOZK Veröffentlichungen /von IOZKVitamin B6 Modifies the Immune Cross-Talk between Mononuclear and Colon Carcinoma Cells
/in International Publications, Micronutrients /von 2016-01-01 / 2016;62(1):47-52
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de